Skip to main content
. 2021 Feb 12;13(2):257. doi: 10.3390/pharmaceutics13020257

Table 1.

Median survival of B16-OVA challenged mice.

Vaccine Treatment Median Survival (Days)
Vehicle 23
Sulfated Lactosyl Archaeol (SLA) + Poly (I:C) (No Antigen) 26.5
Ovalbumin synthetic long peptide (OVA SLP) 21
OVA SLP + SLA 21
OVA SLP + Poly (I:C) 30
OVA SLP + SLA + Poly (I:C) 38